About Cardopa 200 mg/5 ml Injection
Dopamine Hydrochloride is a medicine that stimulates the heart and blood vessels. Cardopa 200 mg/5 ml Injection is given by healthcare professionals in hospital settings for certain circulation problems.
There are 2 brands of Dopamine Hydrochloride listed in Bangladesh. 1 of them has a lower unit price than Cardopa.
What is Cardopa 200 mg/5 ml Injection?
Cardopa 200 mg/5 ml Injection is a hospital medicine containing Dopamine Hydrochloride, which belongs to a group of drugs called inotropic sympathomimetics. It works on the heart and blood vessels to improve blood pressure and blood flow in serious conditions such as shock after a heart attack, severe infection, trauma, or kidney failure. It is also used after open heart surgery and in some cases of heart failure. Because it is given by injection and needs close monitoring, it is only used under the supervision of a doctor, usually in a hospital or intensive care setting.
Uses of Cardopa
Cardopa Injection is used to treat serious circulatory problems where blood pressure is dangerously low or shock has developed. These include shock following a heart attack, severe infections, trauma, or kidney failure. It is also used when low blood pressure persists after open heart surgery once blood volume has been corrected, and in some long-term heart failure cases. It helps to support the heart's pumping action and maintain blood flow to vital organs. The doctor decides when this medicine is appropriate.
How to use Cardopa
Cardopa 200 mg/5 ml Injection is given by a doctor or nurse, usually as a slow infusion into a vein. The dose and rate of infusion are determined by the doctor based on the patient's condition and response. It is not for self-administration. Before starting, the doctor may first restore blood volume with appropriate fluids. During treatment, blood pressure, heart rate, and urine output are monitored closely. Always ask the doctor or pharmacist if you have questions about how this medicine is being given.
Side effects of Cardopa
Common side effects include irregular heartbeats, nausea, vomiting, fast heart rate, chest pain, palpitations, shortness of breath, headache, and changes in blood pressure. Less common effects are abnormal heart rhythms, slow heart rate, dilated pupils, and increased blood pressure. In people with existing blood vessel disease, reduced blood flow to the extremities may occur. Rarely, dangerous heart rhythms have been reported. The doctor will monitor for these effects. Report any unusual symptoms to the medical team immediately.
Safety and precautions
Cardopa Injection should not be used by anyone allergic to dopamine or its ingredients, or by people with an adrenal gland tumour (phaeochromocytoma) or certain abnormal heart rhythms such as uncorrected fast rhythms or ventricular fibrillation. It must be given with caution to patients with existing heart or blood vessel disease. If you are pregnant or breastfeeding, tell your doctor, as the benefits and risks will be weighed. Always inform the doctor about all medicines you take, especially monoamine oxidase inhibitors, as these can interact. The doctor decides if this medicine is suitable for you.
Frequently asked questions
What is the price of Cardopa 200 mg/5 ml Injection?
The listed price is ৳ 45.31. Prices can vary, so please check the current price with your pharmacy or on the website.
What does the dosage form and strength mean?
Cardopa is an injection, meaning it is given into a vein by a healthcare professional. The strength 200 mg/5 ml means each 5 ml ampoule contains 200 mg of Dopamine Hydrochloride. The doctor decides the dose and rate of administration.
What is Cardopa Injection used for and what kind of medicine is it?
It is an inotropic sympathomimetic used in hospitals for serious low blood pressure and shock due to heart attack, infection, trauma, or kidney failure, and after open heart surgery. It helps support the heart and circulation. The doctor decides if it is appropriate.
Who should avoid Cardopa Injection or ask the doctor first?
People with an adrenal tumour (phaeochromocytoma), uncorrected fast heart rhythms, ventricular fibrillation, or allergy to dopamine should not receive it. Those with heart or blood vessel disease, pregnant or breastfeeding women, and people taking monoamine oxidase inhibitors should ask the doctor first.
- Strength
- 200 mg/5 ml
Price in Bangladesh
৳ 44.4 ৳ 45.31 2% off unit price
Price updated: 1 Jul 2022
Indications
Dopamine is recommended for the correction of haemodynamic imbalance present in-
- Acute hypotension or shock associated with myocardial infarction, endotoxic septicaemia, trauma and renal failure.
- As an adjunct after open heart surgery, where there is persistent hypotension after correction of hypovolaemia.
- In chronic cardiac decompensation as in congestive failure.
Pharmacology
Dopamine is a preparation of Dopamine hydrochloride which can stimulate α, β and dopamine receptors. It is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). Dopamine is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract and in a few peripheral sympathetic nerves. It produces positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on β-adrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings. Dopamine does not cross the blood-brain barrier and so does not activate dopamine receptors in the brain.
Dosage & Administration
Adult dose: Where appropriate, the circulating blood volume must be restored with a suitable plasma expander or whole blood, prior to administration of dopamine. Begin infusion of dopamine hydrochloride solution at dosage of 2 to 5 micrograms/kg/min in patients who are likely to respond to a modest increment of heart force and renal perfusion.
In more seriously ill patients, begin infusion of dopamine hydrochloride solution at dosage of 5 micrograms/kg/min and increase gradually using 5 to 10 micrograms/kg/min increment up to 20 to 50 micrograms/kg/min as needed. If dosage in excess of 50 micrograms/kg/min are required, it is suggested that urine output should be checked frequently. In patients who do not respond to this doses, additional increments of dopamine may be given in an effort to achieve adequent blood pressure, urine flow and perfusion.
For patients with severe, refractory, chronic congestive heart failure doses should be started on 0.5 to 2 micrograms/kg/min, and the dose increased by 1 to 3 micrograms/kg/min as urinary output increases.
ECG, blood pressure and urine output should be monitored. Cardiac output and pulmonary wedge pressure should be monitored if possible.
Children less than 12 years old: The safety and efficacy of dopamine in children under 12 years has not been established.
Geriatric patients: No variation in dosage is suggested for geriatric patients. However, close monitoring is required for blood pressure, urine flow, and peripheral tissue perfusion.
Interaction
The action of dopamine hydrochloride is potentiated by monoamine oxidase inhibitors (MAOI's). The concurrent administration of cyclopropane or halogenated hydrocarbon anesthetics may cause ventricular arrhythmias. The cardiac effects of dopamine hydrochloride are antagonized by β - adrenergic blocking agents such as Propranolol and Metoprolol. The ergot alkaloids should be avoided because of the possibility of excessive vasoconstriction. Tricyclic antidepressants and guanethidine may potentiate the pressor response to dopamine hydrochloride. Hypotension and bradycardia have been observed in patients receiving Phenytoin. Dopamine hydrochloride may increase the effect of diuretic agents. Peripheral vasoconstriction may be antagonized by α - adrenergic blocking agents, such as Phentolamine. Other vasodilators may also be useful in patients with heart failure, allowing greater inotropic and renal effects without the associated vasoconstriction. Care must be taken to avoid hypotension.
Contraindications
Dopamine hydrochloride is contraindicated in patients with known hypersensitivity to dopamine or any of its ingredients. It should not be used in patients with phaeochromocytoma, uncorrected tachyarrhythmias, or ventricular fibrillation. Dextrose solution without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility of pseudoagglutination of red cells.
Side Effects
The most frequent reported adverse reactions are ectopic beats, nausea, vomiting, tachycardia, anginal pain, palpitations, dyspnoea, headache, hypotension, hypertension and vasoconstriction. Other less frequent adverse reactions are aberrant ventricular conduction, bradycardia, piloerection, mydriasis, widened QRS complex, azotaemia and elevated blood pressure. Peripheral ischemic gangrene in patients with pre-existing vascular disease. Fatal ventricular arrhythmias have been reported on rare occasions.
Pregnancy & Lactation
Animal studies have revealed no evidence of teratogenic effects from dopamine hydrochloride. The drug may be used in pregnant women when in the judgment of the physician the expected benefits outweigh the potential for risk to the fetus. It is not known if dopamine hydrochloride is excreted in breast milk, nor is the effect on the infant known. It is not recommended for breast-feeding mothers unless the expected benefits outweigh any potential risks
Precautions & Warnings
Dopamine hydrochloride should not be administered in the presence of uncorrected tachyarrhythmia or ventricular fibrillation. It is metabolized in the tissues and blood by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). Dopamine hydrochloride and its metabolites are almost completely excreted in the urine. Patients who have been treated with monoamine oxidase inhibitors (MAOI) prior to the administration of dopamine will require substantially reduced dosages of later. The starting dose in such patients should be reduced to at least one-tenth (1/10) of the usual dose. Excess administration of potassium-free solutions may result in significant hypokalemia. The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentration, overhydration, congested states or pulmonary oedema. Closely monitoring is advised in patients with impaired renal and hepatic function.
Hypovolaemia should be corrected where necessary prior to treatment with dopamine hydrochloride. If a disproportionate rise in diastolic blood pressure (i.e. a marked decrease in pulse pressure) is observed, the infusion rate should be decreased and the patients observed carefully for further evidence of predominant vasoconstriction activity, unless such effect is desired. Dopamine hydrochloride infusion should be withdrawn gradually, to avoid unnecessary hypotension. Patients with a history of peripheral vascular disease (e.g. atherosclerosis, arterial embolism, Raynaud's disease, cold injury, diabetic endarteritis and Buerger's disease) should be closely monitored for any changes in color or temperature of the skin in the extremities. If ischemia occurs and is thought to be the result of vasoconstriction, the benefits of continued dopamine hydrochloride infusion should be weighed against the risk of possible necrosis. These changes may be reversed by either decreasing the rate or discontinuing the infusion. Dopamine hydrochloride in 5% dextrose solution should be infused into a large vein whenever possible to prevent the possibility of infiltration of perivascular tissue adjacent to the infusion site. Extravasations may cause necrosis and sloughing of the surrounding tissue. Ischaemia can be reversed by infiltration of the affected area with 10-15ml of saline containing 5 to 10mg Phentolamine mesylate. Dopamine hydrochloride should be used with extreme caution in patients inhaling cyclopropane or halogenated hydrocarbon anaesthetics due to the arterial arrhythmogenic potential. Dextrose solutions should be used with caution in patients with known subclinical or over diabetes mellitus.
Overdose Effects
In case of accidental overdosage, as evidenced by excessive blood pressure elevation, reduce the rate of administration or temporarily discontinue dopamine hydrochloride until the patients condition stabilized. Since the duration of action of dopamine hydrochloride is quite short, no additional measures are usually necessary. If these measures fail to stabilize the patient's condition, use of the short-acting α-adrenergic blocking agent such as Phentolamine should be considered.
Storage Conditions
Store below 25°C and protect from light.
Alternative brands of Dopamine Hydrochloride
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.